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ABSTRACT
Objective: To evaluate the effects of intra-articular injections 
of corticosteroids, native hyaluronic acid and branched-chain 
hyaluronic acid in experimentally-induced osteoarthrosis. Meth-
ods: 44 rabbits underwent anterior cruciate ligament resec-
tion and were then divided into four groups of eleven. Group 
1: one intra-articular injection of saline solution per week, for 
three weeks; Group 2: three injections (one per week) of native 
hyaluronic acid; Group 3: three injections (one per week) of 
branched-chain hyaluronic acid; Group 4: two injections of be-
tamethasone with an interval of three weeks. The cartilage of the 
tibial plateaus was evaluated macroscopically twelve weeks after 
surgery. Changes to the joint surface were graded as follows: 
Grade 0: smooth joint surface without relief changes; Grade 
1: rough surface without any depressions; Grade 2: similar to 
grade 1, but with depressions on the joint surface; and Grade 3: 
subchondral bone exposure. The statistical analysis consisted of 
the use of Student’s t test, chi-square test and analysis of vari-
ance (ANOVA). The significance level used was 5%. Results: A 
statistical difference was found between the control group and 
the three study groups (2, 3 and 4) in relation to the develop-
ment and severity of arthrosis. However, there was no difference 
between the groups regarding the drugs studied. Conclusion: 
A similar degree of attenuation of the osteoarthrosis process 
in the rabbits’ knees was found with the use of intra-articular 
injections of low-molecular-weight and high-molecular-weight 
glycosaminoglycans, and the corticosteroid betamethasone, 
compared with placebo.
Keywords – Hyaluronic acid. Anterior cruciate ligament; Os-
teoarthritis; Knee; Rabbits
INTRODUCTION
Osteoarthrosis is the most common joint disease 
among the elderly population. Its prevalence is greater 
than 10% among individuals over the age of 50 years 
and it may cause significant functional limitations(1,2). 
Among the different types of treatment available today, 
therapy with intra-articular injections of hyaluronic acid 
has shown beneficial effects in relation to controlling the 
symptoms of gonarthrosis(3).
Hyaluronic acid, which is a polysaccharide in the glyco-
saminoglycan family, contributes towards homeostasis in 
normal joints and presents lower concentrations and 
diminished molecular weight in the synovial fluid of 
joints with osteoarthrosis(4-6). When administered in the 
form of intra-articular injections, hyaluronic acid may 
increase the power of the regenerative effects of endoge-
nous hyaluronic acid on the joint cartilage, by restoring 
the viscoelasticity of the synovial fluid, contributing to-
wards synthesis of hyaluronic acid by synoviocytes and 
preventing degradation of proteoglycans and collagen 
fibers in the extracellular matrix. It stimulates the meta-
bolism, prevents apoptosis of chondrocytes and inhibits 
chondral degradation and inflammatory responses in 
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the joints(6). These therapeutic effects from hyaluronic 
acid are attributed not only to its capacity to ease the 
symptoms relating to osteoarthrosis, but also to its inter-
ference with the progression of joint degeneration(4,5).
Another therapeutic option for managing gonarthro-
sis is intra-articular injections of corticosteroids. Clini-
cal studies have shown favorable results with regard to 
pain relief and functional improvement following intra-
articular injections of betamethasone disodium phos-
phate, betamethasone acetate or methylprednisolone(7,8). 
Intra-articular administration of corticosteroids at low to 
moderate doses may reduce the progression of cartilage 
erosion and the formation of osteophytes(9). In addition 
to suppressing the production of metalloproteinases, 
which have been implicated in the genesis of osteoar-
throsis, it has the capacity to partially prevent destruc-
tion of cells and tissues of the cartilaginous matrix by 
oxygen free radicals(10,11).
In view of the widespread occurrence and implica-
tions of knee osteoarthrosis, the importance of diagno-
sing and treating it at its initial stages, in order to mini-
mize its consequences, is now understood(12). Because 
no interventions capable of inhibiting its evolution are 
currently available, what remain are options that allow 
its progression to be reduced. Intra-articular injections 
of different types of hyaluronic acid and corticosteroids 
may be used for this purpose.
To evaluate the effects of these substances on go-
narthrosis, it was proposed in this investigation to use 
an experimental model for osteoarthrosis that would 
resemble what is observed in humans. Sectioning of 
the anterior cruciate ligament of rabbits’ knees mimics 
the morphological and biochemical changes that are ob-
served in human osteoarthrosis, which enables accurate 
reproduction of the results obtained(13-14).
The aim in this study was to evaluate the effect 
of intra-articular injections of native hyaluronic acid 
(Polireumin®, TRB Pharma, São Paulo, Brazil), bran-
ched-chain hyaluronic acid (Synvisc®, Novartis, São 
Paulo, Brazil) and the corticosteroid betamethasone 
(Diprospan®, Schering-Plough, São Paulo, Brazil), sepa-
rately and in comparison with each other, in osteoarthro-
sis induced by sectioning the anterior cruciate ligament 
in rabbits’ knees.
METHODS
Forty-four male rabbits of the California breed were 
used. They were kept housed in cages (two animals per 
cage) in a vivarium, before and while performing the 
procedures. They received standard feed and had free 
access to water. The lighting conditions were control-
led, with light-dark cycles of 12 hours each, and the 
temperature (22 ± 1ºC), humidity and noise levels were 
kept stable. These conditions were maintained until the 
rabbits reached a mean weight of 3.5 kg.
All the animals firstly underwent resection of the 
anterior cruciate ligament.
The surgical procedure consisted of preoperative 
anesthesia using 10 mg/kg of ketamine hydrochloride 
(Dopalen®) and 50 mg/kg of xylazine hydrochloride 
(Anasedan®), administered in the same syringe, intra-
muscularly into the belly of the semimembranosus and 
semitendinosus muscles of the right hind leg. On the 
same occasion, injections of 14,400 IU of penicillin 
and 6 mg of streptomycin (Pentabiótico Veterinário Re-
forçado® - Eurofarma) were administered as antibiotic 
prophylaxis, and Flunamine® (Bayer), at a dose of 2.2 
mg/kg intramuscularly, was administered for postope-
rative analgesia.
The right knee was shaved and antisepsis consisting 
of polyvinylpyrrolidone (Povidone®) was applied. After 
setting up sterile fields, a medial parapatellar incision 
was made in the skin and subcutaneous tissue, followed 
by capsulotomy and lateral luxation of the patella.
The knee was then positioned at maximum flexion, 
which allowed the anterior cruciate ligament to be 
viewed. This was sectioned using a no. 15 scalpel blade, 
the joint was irrigated with isotonic saline solution and 
then capsulorrhaphy and skin suturing were performed 
using 4-0 mononylon (Figure 1).
The rabbits continued to be housed in their respective 
cages after the operation, without restriction on placing 
weight on the operated leg. They were distributed ran-
domly into four groups of 11 animals each. Three weeks 
after the surgical procedure, the respective intra-articular 
injections were started.
Group 1: control, injections of isotonic saline solu-
tion at one-week intervals, for three weeks.
Group 2: three infiltrations at one-week intervals, 
using native hyaluronic acid (Polireumin®).
Group 3: three infiltrations at one-week intervals, 
using branched-chain hyaluronic acid (Synvisc®).
Group 4: two infiltrations separated by a three-week 
interval, using betamethasone 0.25 mg as the dipropio-
nate and 0.1 mg as the phosphate  (Diprospan®).
One rabbit in group 2 and another in group 3 evolved 
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Figure 1 – Photographs demonstrating the surgical exposure of the anterior cruciate ligament and the closure of the skin after 
the resection
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with infection of the operative site that extended to the 
joint, and were excluded from the study.
The rabbits were killed 12 weeks after the opera-
tion. For this, they were firstly anesthetized as described 
above and then subjected to intracardiac injection of 
thiopental (5 ml) and potassium chloride (10 ml).
The tibial plateaus were resected aseptically, and 
were immersed in a flask containing 10% formol, for 
subsequent macroscopic evaluation of the joint carti-
lage.
The changes to the joint surface were graded macros-
copically as follows: grade 0 – smooth and shiny joint 
surface, without abnormalities of relief; grade 1 – rou-
gh surface, with loss of shininess, without depressions; 
grade 2 – similar to grade 1, with depressions on the 
surface; grade 3 – exposure of the subchondral bone 
(Figure 2). The lateral and medial tibial plateaus were 
evaluated separately in each group.
The statistical analysis consisted of using Student’s 
t test to determine whether there were any differences 
between the different groups in relation to the degrees 
of osteoarthrosis, viewed macroscopically. To determi-
ne whether there were any internal differences in the 
groups regarding the degree of osteoarthrosis in the 
lateral and medial compartments, the chi-square test 
was performed. To investigate differences between the 
degrees of osteoarthrosis, independent of the drug used, 
analysis of variance (Anova) was used.
RESULTS
Osteoarthrosis induced by resection of the anterior 
cruciate ligament occurred in the placebo group in both 
compartments in all the knees. In groups 2, 3 and 4, it 
occurred in 40%, 65% and 45% of the compartments, 
respectively (Table 1 and Figure 3).
Table 1 – Frequencies of the different degrees of osteoarthrosis 
in the medial and lateral compartments of the study groups
Disease 
grade
placebo % Polireumin % Synvisc % corticoid %
G0 0 0.00 12 60.00 7 35.00 12 54.54
G1 13 59.09 1 5.00 7 35.00 7 31.82
G2 5 22.73 7 35.00 6 30.00 3 13.64
G3 4 18.18 0 0.00 0 0.00 0 0.00
Total 22 100.00 20 100.00 20 100.00 22 100.00
The significance level used for all the analyses was 
5%.
Student’s t test was used to compare the different 
drugs and the placebo, regarding the development of 
osteoarthrosis. A statistical difference was observed 
between each of the groups 2, 3 and 4 and the control 
group (Table 2), but there were no differences among 
the drug groups, taking p < 0.05.
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Figure 2 – Macroscopic classification of the tibial plateaus: A) grade 0; B) grade 1 (arrow: loss of shininess; roughness); C) grade 2 
(arrow: surface depression); D) grade 3 (arrow: exposure of subchondral bone)
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Table 2 – Student’s t test
Drugs Calculated t
Synvisc/ corticoid 0.8232
Synvisc/ Polireumin 1.0000
Corticoid/ Polireumin 0.8790
The critical t value for all the comparisons was 2.7764
Significance level of 5%
Through Anova, it was seen that there was a diffe-
rence between different degrees of osteoarthrosis, inde-
pendent of the drug used (Table 3).
Table 3 – Variance test (Anova)
Source of variance F P value
Disease grade 6.5890 0.025
Comparison of the degree of osteoarthrosis within 
each group, between the medial and lateral compart-
ments, showed that there was no significant difference 
in any of the study groups, according to the chi-square 
test (Table 4).
Table 4 – Chi-square test
Drugs calculated
placebo 0.8707
Synvisc 0.0631
corticoid 0.1066
Polireumin 0.0040
Chi-square value tabulated with significance of 0.05 and one degree of freedom was 3.84
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Figure 3 – Occurrence of osteoarthrosis according to the grade 
in the tibial plateaus in the different groups
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DISCUSSION
In this experiment, the joint cartilage of the medial and 
lateral tibial plateaus of the rabbits’ knees that were sub-
jected to sectioning of the anterior cruciate ligament and 
to infiltrations of hyaluronates, corticosteroid and isotonic 
saline solution (control) were evaluated macroscopically. 
The definitions of the different degrees of osteoarthro-
sis were based on observations of the appearance of the 
joint cartilage surface, going from normal (grade 0) to 
complete destruction of the cartilage and exposure of the 
subchondral bone (grade 3). Based on this classification, 
it was observed that, in all the knees infiltrated with iso-
tonic saline solution, there was some degree of chondral 
lesion and severe joint degeneration (grade 3) in 18%. In 
the other groups, there were cases that did not evolve to 
arthrosis, and the maximum that was observed was chan-
ges to the joint surface relief (Table 1 and Figure 3).
lone with injections of hyaluronic acid, in an experimental 
osteoarthrosis model in rabbits, and observed that the two 
drugs administered separately prevented joint degenera-
tion to the same extent, while the effect was boosted when 
the drugs were administered together.
For the infiltrations with corticosteroids, doses pro-
portional to those of human treatments were used, thereby 
avoiding worsening of the chondral lesions due to excess 
medication. The protective effect on chondral bone that 
has been observed in different studies occurred with the 
use of corticosteroids in low doses. The three-week inter-
val between the applications of corticosteroid was used 
because corticosteroids are less soluble and may remain 
inside the joint for this period(19).
Yoshimi et al(4) developed the osteoarthrosis model 
involving sectioning the anterior cruciate ligament in 
rabbits’ knees. In comparison with other models, such 
as partial medial meniscectomy in rabbits and sectioning 
the anterior cruciate ligament in dogs or rats, their model 
is the one that comes closest to the joint degeneration 
process in humans(20-25). Published studies  in the litera-
ture that used this model to evaluate the protective effect 
on chondral bone of glycosaminoglycans and corticoste-
roids have mostly demonstrated that the control groups 
develop arthrosis(4,5,8-10,14,15,24-26). However, contrary to 
experimental studies, recent randomized prospective 
clinical trials have not proven the protective effect on 
chondral bone of different types of hyaluronic acid and 
corticosteroid. What is presented as evidence is the im-
provement in pain levels and functional ability regarding 
activities of daily living among patients who made use 
of these medications over short periods(27-38). Control-
led studies with longer follow-up periods are needed in 
order to clarify the role of these drugs in prevention of 
degeneration of the joint cartilage.
In a continuation of this investigation, it is intended to 
use histological analysis and histomorphometric quanti-
fication of glycosaminoglycans in the extracellular ma-
trix to assess the influence of these substances on the 
osteoarthrosis model used here.
CONCLUSION
From the present study, it is concluded that attenu-
ation of the process of osteoarthrosis takes place to the 
same extent through the use of intra-articular injections 
of low molecular weight glycosaminoglycans, high mo-
lecular weight glycosaminoglycans and corticosteroid 
composed of betamethasone dipropionate and betame-
thasone disodium phosphate, in rabbits’ knees.
The results demonstrated that there was a statistical 
difference with regard to prevention of chondral lesions, 
between the placebo group and the groups that received 
joint injections of different types of hyaluronic acid or 
corticosteroid (Table 2). There was no predominance of 
joint lesions between the lateral and medial tibial compart-
ments in any of the groups (Table 4). In the same way as 
shown by other studies in the literature, the present study 
demonstrated that the intra-articular injections of low and 
high molecular weight glycosaminoglycans and corticos-
teroid had a protective effect on the chondral bone(5,15-18). 
This is also in agreement with the study by Karakurum et 
al(8), who compared intra-articular injections of predniso-
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